TERN- Terns Pharmaceuticals, Inc.

Name: Terns Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Terns Pharmaceuticals, Inc. (TERN) has 9 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. TERN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Burroughs Amy L.	984.7K	-	-
Other	Kuriakose Emil	106.6K	-	-
CFO	Gengos Andrew	101.8K	-	-
Dir	Fellows David A	2.8K	-	-
Dir	Azelby Robert	1.7K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 7, 2022	Lu Hongbo59	Director	Buy	600,000	$3.60	$2,160,000.00	+20.1%	+54.2%	+37.6%
Aug 16, 2022	Orbimed Advisors LLC66	Director, 10% Owner	Buy	3,690,000	$2.42	$8,929,800.00	+97.3%	-7.2%	+14.3%
Aug 16, 2022	Gordon Carl L74	Director, 10% Owner	Buy	3,690,000	$2.42	$8,929,800.00	+97.3%	-7.2%	+14.3%
Aug 16, 2022	Lu Hongbo59	Director	Buy	2,624,239	$2.66	$6,980,244.40	+79.1%	-7.2%	+14.3%
Aug 16, 2022	Vivo Opportunity, LLC67	10% Owner	Buy	2,624,239	$2.66	$6,980,244.40	+79.1%	-7.2%	+14.3%
May 31, 2022	Sundaram Senthil Vel56	Chief Executive Officer	Buy	7,656	$1.47	$11,254.32	New	+145.7%	+513.3%
May 31, 2022	Vignola Mark J.67	Chief Financial Officer	Buy	7,656	$1.47	$11,254.32	New	+145.7%	+513.3%
May 31, 2022	Yoon Seokho Bryan62	COO And General Counsel	Buy	7,656	$1.47	$11,254.32	New	+145.7%	+513.3%
Feb 9, 2021	Flynn James E	10% Owner, Possible Member Of 10% Group	Buy	665,000	$17.00	$11,305,000.00	+38.7%	-	-
Feb 9, 2021	Gordon Carl L74	Director, 10% Owner	Buy	475,000	$17.00	$8,075,000.00	+14.3%	-	-

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC